Clinical Trials Browser

Interventional × Oligodendroglioma × Sorafenib × Clear all

NCT00093613 2014-05-30

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma